Time for united action on depression: a Lancet–World Psychiatric Association Commission

H Herrman, V Patel, C Kieling, M Berk, C Buchweitz… - The Lancet, 2022 - thelancet.com
Executive summary “Depression is a disorder of mood, so mysteriously painful and elusive
in the way it becomes known to the self—to the mediating intellect—as to verge close to …

Major depression and its recurrences: life course matters

SM Monroe, KL Harkness - Annual review of clinical psychology, 2022 - annualreviews.org
Major depression is one of the most prevalent and debilitating personal and public health
conditions worldwide. Less appreciated is that depression's tremendous burdens are not …

Animal models of major depression: drawbacks and challenges

B Planchez, A Surget, C Belzung - Journal of Neural Transmission, 2019 - Springer
Major depression is a leading contributor to the global burden of disease. This situation is
mainly related to the chronicity and/or recurrence of the disorder, and to poor response to …

Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis

M Kennis, L Gerritsen, M van Dalen, A Williams… - Molecular …, 2020 - nature.com
Leading biological hypotheses propose that biological changes may underlie major
depressive disorder onset and relapse/recurrence. Here, we investigate if there is …

Mental health prediction using machine learning: taxonomy, applications, and challenges

J Chung, J Teo - Applied Computational Intelligence and Soft …, 2022 - Wiley Online Library
The increase of mental health problems and the need for effective medical health care have
led to an investigation of machine learning that can be applied in mental health problems …

Adult mental health outcomes of adolescent depression: A systematic review

D Johnson, G Dupuis, J Piche… - Depression and …, 2018 - Wiley Online Library
Background Adolescent depression may increase risk for poor mental health outcomes in
adulthood. The objective of this study was to systematically review the literature on the …

[HTML][HTML] Psychiatry & the psychedelic drugs. Past, present & future

JJH Rucker, J Iliff, DJ Nutt - Neuropharmacology, 2018 - Elsevier
The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and
mescaline, were used extensively in psychiatry before they were placed in Schedule I of the …

[HTML][HTML] The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder

T Perera, MS George, G Grammer, PG Janicak… - Brain stimulation, 2016 - Elsevier
Abstract Background Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated
daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved …

[HTML][HTML] Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis

JEJ Buckman, A Underwood, K Clarke… - Clinical psychology …, 2018 - Elsevier
Purpose To review and synthesise prognostic indices that predict subsequent risk,
prescriptive indices that moderate treatment response, and mechanisms that underlie each …

A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments

P Cuijpers, M Berking, G Andersson… - The Canadian …, 2013 - journals.sagepub.com
Objective: No recent meta-analysis has examined the effects of cognitive-behavioural
therapy (CBT) for adult depression. We decided to conduct such an updated meta-analysis …